On the day the top drug regulator at the Food and Drug Administration resigned amid an investigation into his conduct, he also faced an explosive lawsuit that includes a series of incendiary texts and emails he is said to have sent to a former business associate.
George Tidmarsh, who led the FDA’s Center for Drug Evaluation and Research, stepped down Sunday after being placed on leave in recent days, STAT reported Sunday. At the same time, however, a lawsuit was filed against him in federal court by the Canadian drugmaker Aurinia Pharmaceuticals, alleging he defamed the company and had used his perch to advance a “longstanding personal vendetta” against Kevin Tang, once a Tidmarsh business partner and currently chairman of Aurinia.
Tidmarsh, who only took over the position this summer, has denied wrongdoing.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
Source link
:max_bytes(150000):strip_icc()/Top-Nutrients-for-Better-Blood-Pressure-0b69ef92a80f472ab69bea4c7ed32c7c.jpg "The Top Four Nutrients for Better Blood Pressure")
